871 related articles for article (PubMed ID: 16394033)
1. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
2. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
3. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
[TBL] [Abstract][Full Text] [Related]
4. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
[TBL] [Abstract][Full Text] [Related]
8. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.
Pandya PP; Snijders RJ; Johnson SP; De Lourdes Brizot M; Nicolaides KH
Br J Obstet Gynaecol; 1995 Dec; 102(12):957-62. PubMed ID: 8652486
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
[TBL] [Abstract][Full Text] [Related]
10. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
11. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ; Snijders RJ; Hughes K; Sepulveda W; Nicolaides KH
Br J Obstet Gynaecol; 1996 Oct; 103(10):999-1003. PubMed ID: 8863698
[TBL] [Abstract][Full Text] [Related]
13. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
14. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
15. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy.
Nicolaides KH; Brizot ML; Snijders RJ
Br J Obstet Gynaecol; 1994 Sep; 101(9):782-6. PubMed ID: 7947527
[TBL] [Abstract][Full Text] [Related]
16. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
[TBL] [Abstract][Full Text] [Related]
17. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
[TBL] [Abstract][Full Text] [Related]
18. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.
Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH
Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007
[TBL] [Abstract][Full Text] [Related]
19. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
20. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
